Search clinical trials for: Insulin pump with CGM

Total 490 results

Centre Hospitalier du Luxembourg

Completed

QUality of Control and slEep in Children With diabeteS, Using New Technology (QUEST)

Diabetes Mellitus, Type 1

Luxembourg
University of Cambridge
Norfolk and Norwich University Hospitals NHS Foundation Trust; Barts & The... and other collaborators

Recruiting

Closing the Loop in People With Type 1 Diabetes (CLEAR Phase 2)

Type 1 Diabetes

United Kingdom
University of Cambridge
Cambridge University Hospitals NHS Foundation Trust

Completed

Closing the Loop in Adults With Type 1 Diabetes (CLEAR)

Type 1 Diabetes

United Kingdom
Tandem Diabetes Care, Inc.
Jaeb Center for Health Research

Active, not recruiting

A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes (2IQP)

Type 2 Diabetes Treated With Insulin

United States, Canada
Massachusetts General Hospital
Boston University

Completed

A Multicenter Study of Outpatient Automated Blood Glucose Control With a Bihormonal Bionic Pancreas

Diabetes Mellitus Type 1

United States
Diabetes Care Center
Animas Corporation

Completed

Diabetes Mellitus Type 2 Basal Insulin Dosing Requirements Study

Type 2 Diabetes Mellitus

United States
Steen Andersen
Medtronic

Completed

Effect of CSII and CGM on Progression of Late Diabetic Complications

Type 1 Diabetes Mellitus

Denmark
Imperial College London
London Ambulance Service

Terminated

Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe Hypoglycaemia (AIR-CGM)

Hypoglycemia | Diabetes Mellitus, Type 1 | Hypoglycemia Unawareness

United Kingdom
Ain Shams University

Completed

The Use of CGMS to Detect Alterations of Blood Glucose in Thalassemic Patients

Diabetes | Prediabetes | B-Thalassemia
VitalAire

Not yet recruiting

Impact of the Use of a Closed-loop Insulin Therapy on the Burden of the Diabetes and the Quality of Life (IMPLIQUE)

Quality of Life | Burden, Dependency
Sansum Diabetes Research Institute
Mayo Clinic; University of Padova; University of Virginia; University of California...

Completed

Early Feasibility Study of Zone-MPC and HMS With DiAs in the Outpatient Setting

Diabetes Mellitus, Type 1

United States
Sansum Diabetes Research Institute
Mayo Clinic; University of Padova; University of Virginia; Harvard University; University...

Completed

At Home Study of a Zone-Model Predictive Control (MPC) Controller and a Health Monitoring System (HMS) With the Diabetes Assistant (DiAs) System and Run-to-Run Adaptation

Type 1 Diabetes Mellitus

United States
Emory University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Not yet recruiting

Automated Insulin Delivery for Inpatients With Dysglycemia (AIDING)

Type 1 Diabetes | Type 2 Diabetes

United States
Johns Hopkins Bloomberg School of Public Health
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis (GLUMIT-DG)

Diabetic Gastroparesis

United States
University of Virginia
DexCom, Inc.; Tandem Diabetes Care, Inc.

Completed

Artificial Pancreas and Remote Monitoring During a T1DM Youth Ski Camp

Type 1 Diabetes Mellitus

United States
University Hospital, Grenoble

Completed

Study of Insulin Pump in Prevention of Low Glucose Events in Adults With Type 1 Diabetes at Risk of Severe Hypoglycemia (ALPPHY)

Diabetes, Type 1

France
University of Cambridge
University of Oxford; University of Edinburgh

Recruiting

Closed-loop for People Living With Cystic Fibrosis Related Diabetes (CL4P-CF)

Cystic Fibrosis-related Diabetes

United Kingdom
Medtronic Diabetes

Completed

SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c (SWITCH)

Diabetes Mellitus, Type 1

Netherlands, Slovenia, Denmark, Austria, Italy, Luxembourg, Spain
University of Colorado, Denver
Cystic Fibrosis Foundation

Terminated

Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management

Cystic Fibrosis-related Diabetes | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children

United States
Children's Hospital of Eastern Ontario
Juvenile Diabetes Research Foundation; Canadian Clinical Trial Network

Completed

Timing of Initiation of Continuous Glucose Monitoring in Established Pediatric Diabetes (The CGM TIME Trial)

Type 1 Diabetes

Canada
Xeris Pharmaceuticals

Completed

Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D

Hypoglycemia

Canada
Kinderkrankenhaus auf der Bult

Completed

Study on the Use of the Insulin Pump Tandem X:2 With Control IQ Algorithm - Update (UNIQUE)

Type 1 Diabetes | Insulin Therapy

Germany
Medtronic Diabetes

Completed

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Type 1 Diabetes

United States
Intermountain Health Care, Inc.
Abbott

Active, not recruiting

Diabetes Discharge Transitional CGM Study (DDT-CGM) (DDT-CGM)

Diabetes Mellitus, Type 2

United States
Tandem Diabetes Care, Inc.
Jaeb Center for Health Research

Completed

Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study

Diabetes Mellitus | Type 1 Diabetes | Insulin Pump

United States
Medtronic Diabetes

Completed

United Kingdom User Evaluation, MiniMed Paradigm® X54 System (X54User)

Diabetes Mellitus, Type 1

United Kingdom
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaborators

Completed

The International Diabetes Closed Loop (iDCL) Trial: Clinical Acceptance of the Artificial Pancreas (DCLP3)

Type 1 Diabetes Mellitus

United States
NiliMedix

Completed

Self Operating of the ADI Insulin Pump By Intended Users - A Usability Study

Diabetes Mellitus

Israel
Georgetown University

Not yet recruiting

Glucose-Guided Eating Pilot (GET CHARGED)

Prediabetes | Postmenopausal | Adolescent and Young Adult (AYA) Cancer Survivors
Tandem Diabetes Care, Inc.
Eli Lilly and Company; Jaeb Center for Health Research

Completed

Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes

Type 1 Diabetes

United States
Hoffmann-La Roche

Completed

A Monocenter, Open-Label Glucose Clamp Study Examining the Metabolic Effect of Insulin Infusion Intervals for Basal Insulin Infusion in Patients With Type I Diabetes

Diabetes Mellitus Type 1

Germany
University of Calgary

Recruiting

Closed-loop Insulin Delivery In Type 1 Diabetes Pregnancies (CIRCUIT) (CIRCUIT)

Glucose Metabolism Disorders | Endocrine System Diseases | Pregnancy Related | Type 1 Diabetes Mellitus | Metabolic Disease

Canada, Australia
Tandem Diabetes Care, Inc.

Completed

Tandem Freedom - Feasibility Trial 1

Diabetes Mellitus, Type 1

New Zealand
Tandem Diabetes Care, Inc.

Completed

Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes

Type 1 Diabetes

United States
CHU de Reims

Completed

Interest of SmartGuard Technology (Predictive System for Stopping Insulin Before Hypoglycemia) in Children With Type 1 Diabetes Treated With Insulin Pump

Diabetes Mellitus, Type 1

France
Medtronic Diabetes

Completed

Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes (STAR1)

Type 1 Diabetes

United States
Oregon Health and Science University
University of Washington

Recruiting

Two Way Crossover Closed Loop MPC vs Control IQ

Type 1 Diabetes

United States
Boston Children's Hospital

Completed

Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age

Type 1 Diabetes Mellitus

United States
Tandem Diabetes Care, Inc.

Completed

Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ)

Type 1 Diabetes

United States
Medtronic Diabetes

Completed

Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration (MIP310)

Type 1 Diabetes

United States
Mannkind Corporation

Completed

Afrezza With Basal Combination (ABC)

Type 1 Diabetes

United States
University of Michigan

Completed

Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes

Pre-diabetes

United States
J.H. DeVries
Rijnstate Hospital; Inreda Diabetic B.V.

Completed

Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format, (APPEL5)

Diabetes Mellitus, Type 1

Netherlands
Becton, Dickinson and Company

Completed

Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 Diabetics

Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Withdrawn

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Chinese PLA General Hospital

Completed

Effect Insulin Pump Therapy to Patients With Diabetic Nephropathy

Insulin Pump Therapy in Treating Diabetic Nephropathy
Sheffield Teaching Hospitals NHS Foundation Trust
King's College Hospital NHS Trust; Cambridge University Hospitals NHS Foundation... and other collaborators

Completed

The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial (REPOSE)

Type 1 Diabetes

United Kingdom
Novo Nordisk A/S

Completed

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Japanese Subjects

Diabetes Mellitus, Type 2 | Diabetes

Japan
Medtronic Diabetes

Completed

Evaluation of Meal Gesture Dosing in Adults With Type 1 Diabetes

Type 1 Diabetes

Israel

Search clinical trials for: Insulin pump with CGM

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations